Sign Up to like & get
recommendations!
0
Published in 2020 at "Acta Neuropathologica"
DOI: 10.1007/s00401-020-02169-z
Abstract: Pediatric supratentorial ependymomas with RELA fusions (RELA-EP) have been identified as a unique novel tumor entity [9, 10]. Fusions between C11orf95 and RELA pathologically activate the NFκB signaling pathway indicated by nuclear accumulation of p65-RelA.…
read more here.
Keywords:
rela;
p16 protein;
cdkn2a deletion;
cdkn2a ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e18516
Abstract: e18516Background: T-lineage acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease that arises in a multistep fashion through acquisition of several genetic aberrations. Absenc...
read more here.
Keywords:
cdkn2a deletion;
deletion tcr;
deletion;
homozygous deletion ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Neurosurgical focus"
DOI: 10.3171/2022.9.focus22427
Abstract: OBJECTIVE The authors aimed to assess the frequency of homozygous CDKN2A deletion in isocitrate dehydrogenase (IDH)-mutant diffuse astrocytomas (grade 2/3) and to narrow down the clinicopathological indications in which the CDKN2A fluorescence in situ hybridization…
read more here.
Keywords:
idh mutant;
grade;
deletion;
resource constrained ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Diagnostics"
DOI: 10.3390/diagnostics10060386
Abstract: Diffuse malignant peritoneal mesothelioma (DMPM) is a rare malignant neoplasm with a poor survival. Although some advances in knowledge have been obtained for the pleural form, much less is known about DMPM. Advantages in terms…
read more here.
Keywords:
deletion;
expression p16;
cdkn2a deletion;
ki67 ... See more keywords